Capricor Therapeutics
Capricor Therapeutics is a clinical-stage biotechnology company that focuses on the discovery, development, and commercialization of cell and exosome-based therapeutics for the treatment and prevention of diseases. Its CAP-1002 is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy and COVID-19. The company was founded in 2005 and is headquartered in Los Angeles, California.
Domain
capricor.com
Country
United StatesIndustry
BiotechnologyEmployees
101-250
Last Funding
$150.0M
Founded
2004
Tech Stack (11 technologies)
Frequently Asked Questions
What technologies does Capricor Therapeutics use?+
Capricor Therapeutics uses 11 technologies including Bootstrap, core-js, Klaro.
What industry is Capricor Therapeutics in?+
Capricor Therapeutics operates in the Biotechnology industry.
Where is Capricor Therapeutics based?+
Capricor Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026